Acasti Pharma (ACST) News Today → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free ACST Stock Alerts C$0.58 +0.01 (+1.75%) (As of 03/27/2023) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAcasti Pharma Inc. (ACST)finance.yahoo.com - April 6 at 8:49 PMAcasti Pharma Inc. Class Aedition.cnn.com - March 14 at 6:59 PMAcasti Pharma (ACST) Price Target Increased by 200.00% to 6.12msn.com - February 25 at 1:18 AMAcasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlightsfinance.yahoo.com - February 12 at 9:22 AMWill Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?finance.yahoo.com - December 25 at 7:28 AMAcasti Pharma (ACST) Earnings Dates & Reportsinvesting.com - November 14 at 7:51 PMAcasti Pharma Inc Class A ACSTmorningstar.com - November 11 at 11:28 AMWhy Acasti Pharma (ACST) Stock Is Exploding Higherbenzinga.com - September 26 at 12:07 PMAcasti to Participate in the H.C. Wainwright Global Investment Conferencetechnews.tmcnet.com - September 6 at 8:45 AMAcasti Pharma, Inc.: Acasti Announces First Quarter 2024 Financial Results and Business Highlightsfinanznachrichten.de - August 11 at 7:09 PMAcasti Pharma Inc.: Acasti Pharma Reports Fiscal Year 2023 Operational Resultsfinanznachrichten.de - June 23 at 8:24 AMAcasti Pharma Reports Fiscal Year 2023 Operational Resultsfinance.yahoo.com - June 23 at 8:24 AMAcasti Announces Appointment of New Scientific Advisory Board Membersfinance.yahoo.com - June 22 at 9:40 AMACST - Acasti Pharma Inc.sg.finance.yahoo.com - June 20 at 4:46 AMClosing Bell: Acasti Pharma Inc up on Monday (ACST)theglobeandmail.com - April 7 at 10:01 AMAcasti Pharma announces CEO transitionseekingalpha.com - April 4 at 1:45 PMAcasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange | Morningstarmorningstar.com - March 16 at 12:34 AMAcasti Pharma to Participate in Oppenheimer 33rd Annual Healthcare Conferencefinance.yahoo.com - March 8 at 9:50 AMWe're Hopeful That Acasti Pharma (CVE:ACST) Will Use Its Cash Wiselyfinance.yahoo.com - March 4 at 10:02 AMAcasti Pharma Recognizes Rare Disease Dayfinance.yahoo.com - March 1 at 6:52 AMHas Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year?msn.com - February 28 at 11:19 AMAcasti Pharma to Present at Sidoti Virtual Investor Conference on January 18benzinga.com - January 13 at 9:33 AMAcasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcriptseekingalpha.com - November 15 at 8:27 AMAcasti Pharma to Present at Q4 Investor Summitit.tmcnet.com - November 9 at 6:45 PMAcasti Pharma to Report Second Quarter 2023 Financialtmcnet.com - November 8 at 2:38 AMAcasti Pharma: Top 10 Undervalued Biotechnology Industry Sector Stocks on TSX Venture Exchange (ACST)theglobeandmail.com - September 17 at 10:40 PMAcasti Pharma to Participate in the Lytham Partners Fall 2022 Investor Conferencefinance.yahoo.com - September 14 at 5:54 PMAcasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Company's Drug Candidate for the Treatment of Ataxia Telangiectasiait.tmcnet.com - September 13 at 4:52 PMAcasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgiafinance.yahoo.com - July 27 at 9:24 AMStock Day Media: Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcastfinanznachrichten.de - July 9 at 6:25 PMAcasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcastfinance.yahoo.com - July 7 at 6:22 PMAcasti Pharma, Inc. (ACST) CEO Jan D'Alvise on Q4 2022 Results - Earnings Call Transcriptseekingalpha.com - June 21 at 4:38 PMAcasti Pharma reports GAAP EPS of $0.27 for FY2022seekingalpha.com - June 21 at 11:38 AMAcasti Pharma Inc. Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Programstockhouse.com - May 23 at 4:51 PMAcasti Pharma CEO to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16thapnews.com - May 12 at 9:48 AMAcasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16thfinance.yahoo.com - March 9 at 11:16 AMAcasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Callfinance.yahoo.com - February 7 at 9:12 AMThinking about buying stock in Naked Brand, Biondvax Pharmaceuticals, eMagin Corp, Red Cat, or Acasti Pharma?benzinga.com - December 22 at 12:07 PMAcasti Pharma CEO to Participate in the Benzinga All Access Event on December 2ndfinance.yahoo.com - November 24 at 10:00 AMAcasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Callfinance.yahoo.com - November 4 at 8:50 AMAcasti Pharma outlines key benefits of recent Grace Therapeutics acquisitionproactiveinvestors.com - October 8 at 5:13 PMAcasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japanfinance.yahoo.com - October 6 at 12:15 PMAcasti Pharma Announces Initiation Of Pharmacokinetic Bridging Study For GTX-104benzinga.com - September 29 at 4:35 PMWhy Shares of Acasti Pharma Slumped Tuesdaymsn.com - August 31 at 3:47 PMAcasti Says 8-For-1 Reverse Stock Split Will Be implemented To Help Regain Nasdaq Compliancebenzinga.com - August 28 at 8:11 AM Get Acasti Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ACST and its competitors with MarketBeat's FREE daily newsletter. Email Address The Hard Truth About Investing For Retirement (Ad)Here’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading. Click To Access This Powerful Training Right Now! ACST Media Mentions By Week ACST Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACST News Sentiment▼0.000.44▲Average Medical News Sentiment ACST News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACST Articles This Week▼00▲ACST Articles Average Week Get Acasti Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ACST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aptose Biosciences News Today Covalon Technologies News Today Ceapro News Today Kane Biotech News Today Reunion Neuroscience News Today Sirona Biochem News Today IBEX Technologies News Today Antibe Therapeutics News Today Resverlogix News Today IMV News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:ACST) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
